Debanjan Dhar, Ph.D

Debanjan Dhar is one of the 3 co-founders of rBIO and an Assistant Professor in the Department of Medicine, Division of Gastroenterology, with extensive background in using mice models for clinical research. Debanjan was instrumental in the creation of the genetic models for rBIO’s cell lines and the testing protocols used for insulin purification. His lab is conducting research into novel treatments for liver diseases, which could be of interest to the Company in future expansions of new pharmaceutical molecules.